The market for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s (SHSE:600196) shares didn’t move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the foundations of the business are strong.
Check out our latest analysis for Shanghai Fosun Pharmaceutical (Group)
How Do Unusual Items Influence Profit?
Importantly, our data indicates that Shanghai Fosun Pharmaceutical (Group)’s profit was reduced by CN¥416m, due to unusual items, over the last year. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that’s hardly a surprise given these line items are considered unusual. If Shanghai Fosun Pharmaceutical (Group) doesn’t see those unusual expenses repeat,…
